Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia.

Gkirkas K, Stamouli M, Thomopoulos T, Kontos F, Kavatha D, Siafakas N, Karagiannidou A, Pournaras S, Antoniadou A, Tsirigotis P.

Biol Blood Marrow Transplant. 2019 Jul 18. pii: S1083-8791(19)30450-1. doi: 10.1016/j.bbmt.2019.07.018. [Epub ahead of print] No abstract available.

PMID:
31326612
2.

Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey.

Idelevich EA, Seifert H, Sundqvist M, Scudeller L, Amit S, Balode A, Bilozor A, Drevinek P, Kocak Tufan Z, Koraqi A, Lamy B, Mareković I, Miciuleviciene J, Müller Premru M, Pascual A, Pournaras S, Saegeman V, Schønheyder HC, Schrenzel J, Strateva T, Tilley R, Wiersinga WJ, Zabicka D, Carmeli Y, Becker K; ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES).

Clin Microbiol Infect. 2019 Apr 10. pii: S1198-743X(19)30143-0. doi: 10.1016/j.cmi.2019.03.024. [Epub ahead of print]

PMID:
30980927
3.

In Vitro and In Vivo Exposure-Effect Relationship of Liposomal Amphotericin B against Aspergillus fumigatus.

Siopi M, Mouton JW, Pournaras S, Meletiadis J.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e02673-18. doi: 10.1128/AAC.02673-18. Print 2019 Jun.

PMID:
30962332
4.

Proportion of asylum seekers carrying multi-drug resistant microorganisms is persistently increased after arrival in the Netherlands.

Ravensbergen SJ, Louka C, Ott A, Rossen JW, Cornish D, Pournaras S, Bathoorn E, Stienstra Y.

Antimicrob Resist Infect Control. 2019 Jan 7;8:6. doi: 10.1186/s13756-018-0455-5. eCollection 2019.

5.

Triple combination of meropenem, colistin and tigecycline was bactericidal in a dynamic model despite mere additive interactions in chequerboard assays against carbapenemase-producing Klebsiella pneumoniae isolates.

Tsala M, Vourli S, Georgiou PC, Pournaras S, Daikos GRL, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2019 Feb 1;74(2):387-394. doi: 10.1093/jac/dky422.

PMID:
30376071
6.

Molecular epidemiology of noroviruses in children in South Greece, 2013-2015.

Siafakas N, Zerva L, Hatzaki D, Lebessi E, Chronopoulou G, Paraskakis I, Pournaras S.

J Med Virol. 2018 Nov;90(11):1703-1711. doi: 10.1002/jmv.25251. Epub 2018 Aug 13.

PMID:
29979816
7.

Characterization of Extensively Drug-Resistant or Pandrug-Resistant Sequence Type 147 and 101 OXA-48-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Patients in an Intensive Care Unit.

Avgoulea K, Di Pilato V, Zarkotou O, Sennati S, Politi L, Cannatelli A, Themeli-Digalaki K, Giani T, Tsakris A, Rossolini GM, Pournaras S.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e02457-17. doi: 10.1128/AAC.02457-17. Print 2018 Jul.

8.

Hospital outbreak due to a Klebsiella pneumoniae ST147 clonal strain co-producing KPC-2 and VIM-1 carbapenemases in a tertiary teaching hospital in Northern Greece.

Protonotariou E, Poulou A, Politi L, Sgouropoulos I, Metallidis S, Kachrimanidou M, Pournaras S, Tsakris A, Skoura L.

Int J Antimicrob Agents. 2018 Sep;52(3):331-337. doi: 10.1016/j.ijantimicag.2018.04.004. Epub 2018 Apr 11.

PMID:
29654892
9.

Changes in antimicrobial resistance of clinical isolates of Acinetobacter baumannii group isolated in Greece, 2010-2015.

Dafopoulou K, Tsakris A, Pournaras S.

J Med Microbiol. 2018 Apr;67(4):496-498. doi: 10.1099/jmm.0.000708. Epub 2018 Mar 5.

PMID:
29504930
10.

A New Marker of Echinocandin Activity in an In Vitro Pharmacokinetic/Pharmacodynamic Model Correlates with an Animal Model of Aspergillus fumigatus Infection.

Meletiadis J, Siopi M, Tsakris A, Mouton JW, Pournaras S.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e02322-17. doi: 10.1128/AAC.02322-17. Print 2018 May.

11.

First reported isolation of an emerging opportunistic pathogen (Elizabethkingia anophelis) from hospital water systems in Greece.

Kyritsi MA, Mouchtouri VA, Pournaras S, Hadjichristodoulou C.

J Water Health. 2018 Feb;16(1):164-170. doi: 10.2166/wh.2017.184.

PMID:
29424730
12.

Exploring colistin pharmacodynamics against Klebsiella pneumoniae: a need to revise current susceptibility breakpoints.

Tsala M, Vourli S, Georgiou PC, Pournaras S, Tsakris A, Daikos GL, Mouton JW, Meletiadis J.

J Antimicrob Chemother. 2018 Apr 1;73(4):953-961. doi: 10.1093/jac/dkx522.

PMID:
29377998
13.

Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.

Layer F, Vourli S, Karavasilis V, Strommenger B, Dafopoulou K, Tsakris A, Werner G, Pournaras S.

J Antimicrob Chemother. 2018 May 1;73(5):1181-1184. doi: 10.1093/jac/dkx524.

PMID:
29360979
14.

Prevalence and mechanisms of resistance to fluoroquinolones in Pseudomonas aeruginosa and Escherichia coli isolates recovered from dogs suffering from otitis in Greece.

Vingopoulou EI, Delis GA, Batzias GC, Kaltsogianni F, Koutinas A, Kristo I, Pournaras S, Saridomichelakis MN, Siarkou VI.

Vet Microbiol. 2018 Jan;213:102-107. doi: 10.1016/j.vetmic.2017.11.024. Epub 2017 Nov 21.

PMID:
29291992
15.

Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis.

Ravensbergen SJ, Louka C, Lokate M, Bathoorn E, Pournaras S, van der Werf TS, de Lange WCM, Stienstra Y, Akkerman OW.

Am J Trop Med Hyg. 2018 Feb;98(2):376-378. doi: 10.4269/ajtmh.17-0544. Epub 2017 Dec 21.

16.

Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin.

Turlej-Rogacka A, Xavier BB, Janssens L, Lammens C, Zarkotou O, Pournaras S, Goossens H, Malhotra-Kumar S.

Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):345-353. doi: 10.1007/s10096-017-3140-3. Epub 2017 Nov 25.

17.

First-year results of an antibiotic stewardship program in a Greek tertiary care hospital.

Chrysou K, Zarkotou O, Kalofolia S, Papagiannakopoulou P, Chrysos G, Themeli-Digalaki K, Tsakris A, Pournaras S.

Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):333-337. doi: 10.1007/s10096-017-3137-y. Epub 2017 Nov 19.

PMID:
29152678
18.

Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.

Kousouli E, Zarkotou O, Politi L, Polimeri K, Vrioni G, Themeli-Digalaki K, Tsakris A, Pournaras S.

Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):43-50. doi: 10.1007/s10096-017-3098-1. Epub 2017 Sep 6.

PMID:
28879405
19.

Performance of the β LACTA™ test for rapid detection of expanded-spectrum cephalosporin-non-susceptible Enterobacteriaceae.

Vrioni G, Mamali V, Zarkotou O, Voulgari E, Dimitroulia E, Themeli-Digalaki K, Pournaras S, Tsakris A.

J Glob Antimicrob Resist. 2017 Sep;10:285-288. doi: 10.1016/j.jgar.2017.05.018. Epub 2017 Jul 18.

PMID:
28732790
20.

Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.

Vourli S, Dafopoulou K, Vrioni G, Tsakris A, Pournaras S.

J Antimicrob Chemother. 2017 Sep 1;72(9):2528-2530. doi: 10.1093/jac/dkx186.

PMID:
28605445
21.

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators.

Lancet Infect Dis. 2017 Jul;17(7):726-734. doi: 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22.

PMID:
28442293
22.

Predominance of international clone 2 OXA-23-producing-Acinetobacter baumannii clinical isolates in Greece, 2015: results of a nationwide study.

Pournaras S, Dafopoulou K, Del Franco M, Zarkotou O, Dimitroulia E, Protonotariou E, Poulou A, Zarrilli R, Tsakris A; Greek Study Group on Acinetobacter Antimicrobial Resistance.

Int J Antimicrob Agents. 2017 Jun;49(6):749-753. doi: 10.1016/j.ijantimicag.2017.01.028. Epub 2017 Apr 18.

PMID:
28427842
23.

Comparative Evaluation of Sensititre YeastOne and CLSI M38-A2 Reference Method for Antifungal Susceptibility Testing of Aspergillus spp. against Echinocandins.

Siopi M, Pournaras S, Meletiadis J.

J Clin Microbiol. 2017 Jun;55(6):1714-1719. doi: 10.1128/JCM.00044-17. Epub 2017 Mar 22.

24.

A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae.

Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Pintado V, Doi Y, Tuon FF, Karaiskos I, Machuca I, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; Investigators from the REIPI/ESGBIS/INCREMENT Group.

Mayo Clin Proc. 2016 Oct;91(10):1362-1371. doi: 10.1016/j.mayocp.2016.06.024. Erratum in: Mayo Clin Proc. 2016 Dec;91(12 ):1843.

PMID:
27712635
25.

In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.

Nepka M, Perivolioti E, Kraniotaki E, Politi L, Tsakris A, Pournaras S.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6903-6906. doi: 10.1128/AAC.01082-16. Print 2016 Nov.

26.

Epidemiological Investigation of Legionella pneumophila Serogroup 2 to 14 Isolates from Water Samples by Amplified Fragment Length Polymorphism and Sequence-Based Typing and Detection of Virulence Traits.

Katsiaflaka A, Pournaras S, Kristo I, Mouchtouri VA, Kyritsi M, Velonakis E, Vatopoulos AC, Hadjichristodoulou C.

Appl Environ Microbiol. 2016 Sep 30;82(20):6102-6108. Print 2016 Oct 15.

27.

Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.

Dimitriadis P, Protonotariou E, Varlamis S, Poulou A, Vasilaki O, Metallidis S, Tsakris A, Malisiovas N, Skoura L, Pournaras S.

Int J Antimicrob Agents. 2016 Sep;48(3):321-3. doi: 10.1016/j.ijantimicag.2016.05.017. Epub 2016 Jul 7.

PMID:
27451087
28.

Reply to "Reliability of Gradient Diffusion Methods for Detection of Acquired Colistin Resistance".

Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4424-5. doi: 10.1128/AAC.00206-16. Print 2016 Jul. No abstract available.

29.

Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance.

Pournaras S, Koumaki V, Spanakis N, Gennimata V, Tsakris A.

Int J Antimicrob Agents. 2016 Jul;48(1):11-18. doi: 10.1016/j.ijantimicag.2016.04.017. Epub 2016 May 17. Review.

PMID:
27256586
30.

Hepatitis B Virus Vaccination Coverage in Medical, Nursing, and Paramedical Students: A Cross-Sectional, Multi-Centered Study in Greece.

Papagiannis D, Tsimtsiou Z, Chatzichristodoulou I, Adamopoulou M, Kallistratos I, Pournaras S, Arvanitidou M, Rachiotis G.

Int J Environ Res Public Health. 2016 Mar 15;13(3). pii: E323. doi: 10.3390/ijerph13030323.

31.

Emergence of OXA-162 Carbapenemase- and DHA-1 AmpC Cephalosporinase-Producing Sequence Type 11 Klebsiella pneumoniae Causing Community-Onset Infection in Greece.

Voulgari E, Poulou A, Dimitroulia E, Politi L, Ranellou K, Gennimata V, Markou F, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1862-4. doi: 10.1128/AAC.01514-15.

32.

Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation.

Dafopoulou K, Xavier BB, Hotterbeekx A, Janssens L, Lammens C, Dé E, Goossens H, Tsakris A, Malhotra-Kumar S, Pournaras S.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1892-5. doi: 10.1128/AAC.02518-15.

33.

West Nile Virus Seroprevalence in the Greek Population in 2013: A Nationwide Cross-Sectional Survey.

Hadjichristodoulou C, Pournaras S, Mavrouli M, Marka A, Tserkezou P, Baka A, Billinis C, Katsioulis A, Psaroulaki A, Papa A, Papadopoulos N, Mamuris Z, Tsakris A, Kremastinou J; MALWEST Project.

PLoS One. 2015 Nov 25;10(11):e0143803. doi: 10.1371/journal.pone.0143803. eCollection 2015.

34.

In Vitro Activity of Tigecycline Against Acinetobacter baumannii: Global Epidemiology and Resistance Mechanisms.

Pournaras S, Koumaki V, Gennimata V, Kouskouni E, Tsakris A.

Adv Exp Med Biol. 2016;897:1-14. doi: 10.1007/5584_2015_5001. Review.

PMID:
26563303
35.

Phylogenetic and genomic diversity in isolates from the globally distributed Acinetobacter baumannii ST25 lineage.

Sahl JW, Del Franco M, Pournaras S, Colman RE, Karah N, Dijkshoorn L, Zarrilli R.

Sci Rep. 2015 Oct 14;5:15188. doi: 10.1038/srep15188.

36.

A glyS T-box riboswitch with species-specific structural features responding to both proteinogenic and nonproteinogenic tRNAGly isoacceptors.

Apostolidi M, Saad NY, Drainas D, Pournaras S, Becker HD, Stathopoulos C.

RNA. 2015 Oct;21(10):1790-806. doi: 10.1261/rna.052712.115. Epub 2015 Aug 14.

37.

Whole-genome analysis of an oxacillin-susceptible CC80 mecA-positive Staphylococcus aureus clinical isolate: insights into the mechanisms of cryptic methicillin resistance.

Sabat AJ, Pournaras S, Akkerboom V, Tsakris A, Grundmann H, Friedrich AW.

J Antimicrob Chemother. 2015 Nov;70(11):2956-64. doi: 10.1093/jac/dkv210. Epub 2015 Jul 20.

PMID:
26198147
38.

Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.

Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2015 Aug;59(8):4625-30. doi: 10.1128/AAC.00868-15. Epub 2015 May 26.

39.

Driving Forces of Mechanisms Regulating Oxacillin-Resistance Phenotypes of MRSA: Truly Oxacillin-Susceptible mecA-Positive Staphylococcus aureus Clinical Isolates also Exist.

Pournaras S, Sabat AJ, Grundmann H, Hendrix R, Tsakris A, Friedrich AW.

Curr Pharm Des. 2015;21(16):2048-53. Review.

PMID:
25760336
40.

Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.

Karavasilis V, Zarkotou O, Panopoulou M, Kachrimanidou M, Themeli-Digalaki K, Stylianakis A, Gennimata V, Ntokou E, Stathopoulos C, Tsakris A, Pournaras S; Greek Study Group on Staphylococcal Linezolid Resistance.

J Antimicrob Chemother. 2015;70(6):1625-9. doi: 10.1093/jac/dkv028. Epub 2015 Feb 23.

PMID:
25712317
41.

Evaluation of a new phenotypic OXA-48 disk test for differentiation of OXA-48 carbapenemase-producing Enterobacteriaceae clinical isolates.

Tsakris A, Poulou A, Bogaerts P, Dimitroulia E, Pournaras S, Glupczynski Y.

J Clin Microbiol. 2015 Apr;53(4):1245-51. doi: 10.1128/JCM.03318-14. Epub 2015 Feb 4.

42.

Non-Invasive Ventilation (NIV) and Homeostatic Model Assessment (HOMA) Index in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients with Chronic Hypercapnic Respiratory Failure: A Pilot Study.

Dimoulis A, Pastaka C, Tsolaki V, Tsilioni I, Pournaras S, Liakos N, Georgoulias P, Gourgoulianis K.

COPD. 2015 Aug;12(4):427-34. doi: 10.3109/15412555.2014.974738.

PMID:
25415619
43.

Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.

Vrioni G, Bourdakis A, Pappas G, Pitiriga V, Mavrouli M, Pournaras S, Tsakris A.

Antimicrob Agents Chemother. 2014 Dec;58(12):7541-4. doi: 10.1128/AAC.03841-14. Epub 2014 Sep 22.

44.

Effect of ceftriaxone on the outcome of murine pyelonephritis caused by extended-spectrum-β-lactamase-producing Escherichia coli.

Tratselas A, Simitsopoulou M, Giannakopoulou A, Dori I, Saoulidis S, Kollios K, Papaioannidou P, Pournaras S, Roilides E.

Antimicrob Agents Chemother. 2014 Dec;58(12):7102-11. doi: 10.1128/AAC.03974-14. Epub 2014 Sep 15.

45.

Linezolid-dependent function and structure adaptation of ribosomes in a Staphylococcus epidermidis strain exhibiting linezolid dependence.

Kokkori S, Apostolidi M, Tsakris A, Pournaras S, Stathopoulos C, Dinos G.

Antimicrob Agents Chemother. 2014 Aug;58(8):4651-6. doi: 10.1128/AAC.02835-14. Epub 2014 Jun 2.

46.

Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages.

Pournaras S, Gogou V, Giannouli M, Dimitroulia E, Dafopoulou K, Tsakris A, Zarrilli R.

J Clin Microbiol. 2014 May;52(5):1653-7. doi: 10.1128/JCM.03565-13. Epub 2014 Mar 12.

47.

Self-sampling for high-risk human papillomavirus detection: future cervical cancer screening?

Daponte A, Pournaras S, Tsakris A.

Womens Health (Lond). 2014 Mar;10(2):115-8. doi: 10.2217/whe.14.8. No abstract available.

PMID:
24601801
48.

Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.

Poulou A, Grivakou E, Vrioni G, Koumaki V, Pittaras T, Pournaras S, Tsakris A.

J Clin Microbiol. 2014 May;52(5):1483-9. doi: 10.1128/JCM.03361-13. Epub 2014 Feb 26.

49.

Growth retardation, reduced invasiveness, and impaired colistin-mediated cell death associated with colistin resistance development in Acinetobacter baumannii.

Pournaras S, Poulou A, Dafopoulou K, Chabane YN, Kristo I, Makris D, Hardouin J, Cosette P, Tsakris A, Dé E.

Antimicrob Agents Chemother. 2014;58(2):828-32. doi: 10.1128/AAC.01439-13. Epub 2013 Nov 18.

50.

Activin A and follistatin as biomarkers for ectopic pregnancy and missed abortion.

Daponte A, Deligeoroglou E, Garas A, Pournaras S, Hadjichristodoulou C, Messinis IE.

Dis Markers. 2013;35(5):497-503. doi: 10.1155/2013/969473. Epub 2013 Oct 7.

Supplemental Content

Loading ...
Support Center